We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Indirect Approach Uses Yeast to Identify Function of Malaria Genes

By LabMedica International staff writers
Posted on 08 Feb 2012
By using DNA segments isolated from a less deadly form of the malaria-causing parasite Plasmodium, researchers have developed an indirect method for assigning functions to the genes of the lethal human parasite P. More...
falciparum.

Although the complete genome of P. falciparum was sequenced in 2002, its high content of adenine and thymine (A and T) moieties has made it almost impossible to determine the precise function of any of its genes.

To overcome this obstacle investigators at National Jewish Health (Denver, CO, USA) and Yale University (New Haven, CT, USA) constructed a cDNA library from P. knowlesi, which has a lower A + T content compared with P. falciparum. Use of DNA segments from P. knowlesi allowed the investigators to take advantage of the large repertoire of genetic tools available for Saccharomyces cerevisiae, which makes this yeast an ideal system for large-scale functional complementation analyses of parasite genes. After establishing the functions of the P. knowlesi genes they could then match them to corresponding genes in P. falciparum.

The investigators reported in the January 2, 2012, issue of the Journal of Biological Chemistry that they had identified the malaria genes involved in the decarboxylation of phosphatidylserine. The gene, phosphatidylserine decarboxylase, directs the formation of a protein unique to malarial parasites and is a potential therapeutic target.

“The malarial genome has been a black box. Our technique allows us to open that box, so that we can learn what genes in the most lethal human parasite actually do,” said senior author Dr. Dennis Voelker, professor of medicine at National Jewish Health. “This could prove tremendously valuable in the fight against a disease that has become increasingly drug-resistant. This technique could lead to an explosion in knowledge about malaria and the parasite that causes it.”

Related Links:
National Jewish Health
Yale University



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.